We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Luye Medical Group to buy Healthe Care

By HospiMedica International staff writers
Posted on 15 Dec 2015
Luye Medical Group (Beijing, China) has entered into an agreement to acquire Australian private hospital operator Healthe Care (Sydney, Australia) for USD 688 million. More...


The third largest corporate private hospital operator in Australia, Healthe Care operates a portfolio of 17 hospital sites in major cities and key regional areas across Australia, with over 1,800 beds, 50 operating theaters, and 4,500 employees. Healthe Care was bought by private-equity firm Archer Capital (Sydney, NSW, Australia) in 2011, and since then has company has steadily expanded with a series of acquisitions, including Townsville Private in 2014 and Robina Private earlier in 2015.

For Luye Medical, the agreement marks the company’s 's first entry into the overseas hospital sector, with stated purpose of helping to meet higher demands on China's healthcare sector. Luye Medical, a division of the Luye Group, currently operates a network of healthcare service facilities across major cities in China, focusing on key therapeutic areas, including rehabilitation nursing, plastic surgery, postpartum nursing, geriatric medicine, and dentistry.

“There are very few private hospital portfolio acquisition opportunities anywhere in the world, and to be able to enter the Australian market with an acquisition of scale such as Healthe Care represents a great opportunity,” said Liu Dian Bo, chairman of Luye Group. “I strongly believe that Healthe Care will provide us with a platform upon which we can build a world class and highly successful healthcare services business not only in Australia and China, but also in many other countries in Asia.”

“I have spent a considerable amount of time over the past several months getting to know the Luye Medical management team and have been impressed by their vision and strong commitment to continue funding the expansion of healthcare services at Healthe Care,” said Steve Atkins, CEO of Healthe Care. “I am looking forward to working with Luye Medical’s executives and benefitting from their healthcare expertise as we further our strong partnerships with Healthe Care’s doctors and staff to deliver the highest standards of patient care.”

Related Links:

Luye Medical Group
Healthe Care
Archer Capital



Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Warming Cabinet
EC1850BL
New
Portable Digital Floor Scale
DR400C
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.